Is Novan, Inc. (NOVN) A Good Stock To Buy?
In this article we will take a look at whether hedge funds think Novan, Inc. (NASDAQ:NOVN) is a good investment right now.
Novan Inc. (NOVN)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 382,665 | $1,508 | +12% | 0% |
| 2. | Two Sigma Advisors John Overdeck And David Siegel | 79,900 | $315 | -11% | 0% |
| 3. | Citadel Investment Group Ken Griffin | 29,212 | $116 | 0% | |
| 4. | Sabby Capital Hal Mintz | 28,838 | $114 | +51% | 0.01% |
| 5. | D E Shaw D. E. Shaw | 16,083 | $63 | -63% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.45 | 1,000 | Director | 4,000 | 2022-04-07 | Filing | |
| $3.45 | 1,000 | Director | 3,000 | 2022-03-28 | Filing | |
| $3.55 | 2,000 | Director | 2,000 | 2022-03-25 | Filing | |
| $3.64 | 10,000 | Director | 69,356 | 2022-03-18 | Filing | |
| $3.50 | 1,000 | Officer | 2,500 | 2022-03-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.75 | 6,287 | Large Shareholder | 2,598,485 | 2019-07-02 | Filing | |
| $2.74 | 913 | Large Shareholder | 2,604,772 | 2019-07-01 | Filing | |
| $2.69 | 17,800 | Large Shareholder | 2,605,685 | 2019-06-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 789,719 | $3,112 | 0% | |
| 2. | 303,038 | $1,194 | 0% | |
| 3. | 144,838 | $570 | 0% | |
| 4. | 127,121 | $501 | 0.06% | |
| 5. | 66,435 | $262 | 0.04% |
News See All
Should You Buy Novan, Inc. (NOVN)?
Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 of 2018 due to various reasons.
Two Biotechs To Watch This Week: Novan Inc (NOVN) And MannKind Corporation (MNKD)
Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors.
Billionaire Hedge Funds
